{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:13:49Z","timestamp":1794366829208,"version":"4.9.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00259-023-06492-x","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T01:00:24Z","timestamp":1698886824000},"page":"2998-3008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A novel PSMA targeted dual-function near-infrared fluorescence and PET probe for the image-guided surgery and detection of prostate cancer"],"prefix":"10.1007","volume":"51","author":[{"given":"Haitian","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-1928","authenticated-orcid":false,"given":"Chunjing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"6492_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"6492_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/cancers12061367","volume":"12","author":"W Jones","year":"2020","unstructured":"Jones W, Griffiths K, Barata PC, Paller CJ. PSMA Theranostics: review of the current status of PSMA-Targeted imaging and Radioligand Therapy. Cancers (Basel). 2020;12(6):1367. https:\/\/doi.org\/10.3390\/cancers12061367.","journal-title":"Cancers (Basel)"},{"key":"6492_CR3","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1021\/acsomega.0c06353","volume":"6","author":"Y Guo","year":"2021","unstructured":"Guo Y, Gao D, Chen Y, Zhang Y, Chen L, Mao Y, et al. Preclinical evaluation of a Fluorine-18 labeled probe for the detection of the expression of PSMA Level in Cancer. ACS Omega. 2021;6:8279\u201387. https:\/\/doi.org\/10.1021\/acsomega.0c06353.","journal-title":"ACS Omega"},{"key":"6492_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00726-021-02997-7","volume":"53","author":"W Zhou","year":"2021","unstructured":"Zhou W, Huang S, Jiang Y, Hu K, Wang L, Han Y, et al. Automatic radiosynthesis and preclinical evaluation of (18)F-AlF-PSMA-NF as a potential PET probe for Prostate cancer imaging. Amino Acids. 2021;53:929\u201338. https:\/\/doi.org\/10.1007\/s00726-021-02997-7.","journal-title":"Amino Acids"},{"key":"6492_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2967\/jnumed.118.218495","volume":"60","author":"BD Zlatopolskiy","year":"2019","unstructured":"Zlatopolskiy BD, Endepols H, Krapf P, Guliyev M, Urusova EA, Richarz R, et al. Discovery of (18)F-JK-PSMA-7, a PET probe for the detection of small PSMA-Positive lesions. J Nucl Med. 2019;60:817\u201323. https:\/\/doi.org\/10.2967\/jnumed.118.218495.","journal-title":"J Nucl Med"},{"key":"6492_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1967\/s002449912437","volume":"25","author":"E Pasini","year":"2022","unstructured":"Pasini E, Panagiotidis E, Zoglopitou LA, Kalathas T, Makridou A, Chatzipavlidou V. Comparative study of the most commonly-used radiopharmaceuticals for PSMA prostate PET\/CT imaging. Hell J Nucl Med. 2022;25:83\u20137. https:\/\/doi.org\/10.1967\/s002449912437.","journal-title":"Hell J Nucl Med"},{"key":"6492_CR7","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1016\/S1470-2045(20)30600-8","volume":"22","author":"LJ Lauwerends","year":"2021","unstructured":"Lauwerends LJ, van Driel P, Baatenburg de Jong RJ, Hardillo JAU, Koljenovic S, Puppels G, et al. Real-time fluorescence imaging in intraoperative decision making for cancer Surgery. Lancet Oncol. 2021;22:e186\u2013e95. https:\/\/doi.org\/10.1016\/S1470-2045(20)30600-8.","journal-title":"Lancet Oncol"},{"key":"6492_CR8","doi-asserted-by":"publisher","unstructured":"Capozza M, Stefania R, Dinatale V, Bitonto V, Conti L, Grange C, et al. A Novel PSMA-Targeted probe for NIRF-Guided Surgery and photodynamic therapy: synthesis and preclinical validation. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232112878.","DOI":"10.3390\/ijms232112878"},{"key":"6492_CR9","doi-asserted-by":"publisher","unstructured":"Zhou H, Liu Y, Zhang X, Chen K, Li Y, Xu X, et al. A preliminary study of PSMA fluorescent probe for targeted fluorescence imaging of Prostate Cancer. Molecules. 2022;27. https:\/\/doi.org\/10.3390\/molecules27092736.","DOI":"10.3390\/molecules27092736"},{"key":"6492_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2967\/jnumed.117.201293","volume":"59","author":"AC Baranski","year":"2018","unstructured":"Baranski AC, Schafer M, Bauder-Wust U, Roscher M, Schmidt J, Stenau E, et al. PSMA-11-Derived dual-labeled PSMA inhibitors for preoperative PET imaging and precise fluorescence-guided Surgery of Prostate Cancer. J Nucl Med. 2018;59:639\u201345. https:\/\/doi.org\/10.2967\/jnumed.117.201293.","journal-title":"J Nucl Med"},{"key":"6492_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2967\/jnumed.114.138180","volume":"55","author":"S Lutje","year":"2014","unstructured":"Lutje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, et al. Dual-modality image-guided Surgery of Prostate Cancer with a Radiolabeled fluorescent Anti-PSMA monoclonal antibody. J Nucl Med. 2014;55:995\u20131001. https:\/\/doi.org\/10.2967\/jnumed.114.138180.","journal-title":"J Nucl Med"},{"key":"6492_CR12","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/1535-7163.MCT-14-0422","volume":"13","author":"X Wang","year":"2014","unstructured":"Wang X, Huang SS, Heston WD, Guo H, Wang BC, Basilion JP. Development of targeted near-infrared imaging agents for Prostate cancer. Mol Cancer Ther. 2014;13:2595\u2013606. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0422.","journal-title":"Mol Cancer Ther"},{"key":"6492_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.clgc.2021.03.011","volume":"19","author":"O Aras","year":"2021","unstructured":"Aras O, Demirdag C, Kommidi H, Guo H, Pavlova I, Aygun A, et al. Small molecule, Multimodal, [(18)F]-PET and fluorescence imaging Agent Targeting prostate-specific membrane Antigen: first-in-human study. Clin Genitourin Cancer. 2021;19:405\u201316. https:\/\/doi.org\/10.1016\/j.clgc.2021.03.011.","journal-title":"Clin Genitourin Cancer"},{"key":"6492_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/1078-0432.CCR-18-0803","volume":"25","author":"SA Kularatne","year":"2019","unstructured":"Kularatne SA, Thomas M, Myers CH, Gagare P, Kanduluru AK, Crian CJ, et al. Evaluation of Novel prostate-specific membrane Antigen-targeted Near-Infrared Imaging Agent for fluorescence-guided Surgery of Prostate Cancer. Clin Cancer Res. 2019;25:177\u201387. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0803.","journal-title":"Clin Cancer Res"},{"key":"6492_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther. 2021;6:201. https:\/\/doi.org\/10.1038\/s41392-021-00572-w.","journal-title":"Signal Transduct Target Ther"},{"key":"6492_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/apjon.apjon_79_17","volume":"5","author":"GM Wilkes","year":"2018","unstructured":"Wilkes GM. Targeted therapy: attacking Cancer with Molecular and Immunological targeted agents. Asia Pac J Oncol Nurs. 2018;5:137\u201355. https:\/\/doi.org\/10.4103\/apjon.apjon_79_17.","journal-title":"Asia Pac J Oncol Nurs"},{"key":"6492_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188\u201396. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.034.","journal-title":"Eur J Pharmacol"},{"key":"6492_CR18","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1021\/acs.bioconjchem.7b00458","volume":"28","author":"AC Baranski","year":"2017","unstructured":"Baranski AC, Schafer M, Bauder-Wust U, Wacker A, Schmidt J, Liolios C, et al. Improving the imaging contrast of (68)Ga-PSMA-11 by targeted Linker Design: Charged Spacer moieties enhance the Pharmacokinetic properties. Bioconjug Chem. 2017;28:2485\u201392. https:\/\/doi.org\/10.1021\/acs.bioconjchem.7b00458.","journal-title":"Bioconjug Chem"},{"key":"6492_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2967\/jnumed.118.221671","volume":"60","author":"T Liu","year":"2019","unstructured":"Liu T, Liu C, Xu X, Liu F, Guo X, Li N, et al. Preclinical evaluation and pilot clinical study of Al(18)F-PSMA-BCH for Prostate Cancer PET imaging. J Nucl Med. 2019;60:1284\u201392. https:\/\/doi.org\/10.2967\/jnumed.118.221671.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06492-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06492-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06492-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T08:06:40Z","timestamp":1722845200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06492-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["6492"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06492-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"22 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest relevant to this article exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was granted by the Ethics Committee of Jiangnan University. The study involving human participants was in line with the principles of the ethics committee of Affiliated Hospital of Jiangnan University and the Declaration of Helsinki in 1964.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}